CBD Life Sciences Inc.

OTC: CBDL · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ Scottsdale, AZ · MaricopaCIK 0001776073Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 35

v0.1 · 5/100 weight · pillars only

↑ listing tenure, Piotroski F · ↓ workforce scale, market scale

Methodology →

Revenue TTM

$80.4k

Rev growth YoY (TTM)

-42.2%

Net income (FY)

—

Employees

as of 2026-08-27

Market cap

$375.4k

as of 2026-08-27

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is CBD Life Sciences Inc.’s financial profile?

CBD Life Sciences Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Halberd Corporation——IM Cannabis Corp.——Southern Home Medical, Inc.——Galexxy Holdings, Inc.——LiveCare, Inc.——Resilient Healthcare Corp——

Neighbors

Maricopa →

Southern Copper Corporation$13.4B89A Freeport-McMoRan Inc.$25.2B77B+Carvana Co.$20.3B70B Honeywell Aerospace Inc. Common Stock When Issued$17.4B——Republic Services, Inc.$16.6B81B+Axon Enterprise, Inc.$2.8B64C

Key facts

CEOLisa Anne Nelson

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersScottsdale, AZ

ExchangeOTC: CBDL

Employees3

IPO date2009-09-11

Latest filings

No filings loaded.

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.